Terazosin Hydrochloride
Overview
Terazosin Hydrochloride is an alpha-1 adrenergic blocker used to treat high blood pressure and benign prostatic hyperplasia. It works by relaxing the muscles in the prostate and part of the bladder, making it easier to urinate and lowering blood pressure.
API suppliers (10)
Suppliers of Terazosin Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 10 suppliers.
2 of 10 hold a GMP certificate on record in the EU or UK registers
- JUBILANT BIOSYS LTDIndia1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
- TAPI NL BVNetherlands1 active DMF
- PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
- ARCHIMICA SRL GMP on record
- STANDARD CHEM AND PHARM CO LTD
- PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
- SECOND PHARMA CO LTDChina
- SUMITOMO CHEMICAL CO LTDJapan GMP on record
- BASF PHARMACHEMIKALIEN GMBH CO KG
Therapeutic areas
Do you supply Terazosin Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.